DAB2IP regulates autophagy in prostate cancer in response to combined treatment of radiation and a DNA-PKcs inhibitor

Neoplasia (United States)

Volumn 14, Issue 12, 2012, Pages 1203-1212

  Yu, Lan ^a   Tumati, Vasu ^a   Tseng, Shu Fen ^b   Hsu, Feng Ming ^c   Kim, D Nathan ^a   Hong, David ^a   Hsieh, Jer Tsong ^a,d   Jacobs, Corbin ^a   Kapur, Payal ^a   Saha, Debabrata ^a,d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b University of Texas at Arlington   (United States)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (1 CYANO 1 METHYLETHYL) 3 METHYL 8 (3 QUINOLINYL) IMIDAZO [4, 5 C] QUINOLIN 2 (1H, 3H) ONE; 1 (1 CYANO 1 METHYLETHYL) 3 METHYL 8 (3 QUINOLINYL)IMIDAZO[4,5 C]QUINOLIN 2(1H,3H) ONE; 2 MORPHOLINO 8 PHENYLCHROMONE; BAFILOMYCIN A1; BECLIN 1; DNA DEPENDENT PROTEIN KINASE; DOC 2 DAB2 INTERACTING PROTEIN; EVEROLIMUS; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; HISTONE H2AX; MAMMALIAN TARGET OF RAPAMYCIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NU 7441; PROTEIN KINASE INHIBITOR; RAPAMYCIN; S6 KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUTOPHAGY; CELL CYCLE; CELL SURVIVAL; CLONOGENIC ASSAY; COHORT ANALYSIS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; INFRARED RADIATION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RADIOSENSITIVITY; RETROSPECTIVE STUDY; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; WESTERN BLOTTING;

EID: 84871550160     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.121310     Document Type: Article

References (39)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, and Thun MJ (2009). Cancer statistics, 2009. CA Cancer J Clin 59, 225-249.
2. Hanks GE, Pajak TF, Porter A, Grignon D, Brereton H, Venkatesan V, Horwitz EM, Lawton C, Rosenthal SA, Sandler HM, et al. (2003). Phase III trial of longterm adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02. J Clin Oncol 21, 3972-3978.
3. Tomioka A, Tanaka M, De Velasco MA, Anai S, Takada S, Kushibiki T, Tabata Y, Rosser CJ, Uemura H, and Hirao Y (2008). Delivery of PTEN via a novel gene microcapsule sensitizes prostate cancer cells to irradiation. Mol Cancer Ther 7, 1864-1870.
4. Chen H, Pong RC, Wang Z, and Hsieh JT (2002). Differential regulation of the human gene DAB2IP in normal and malignant prostatic epithelia: cloning and characterization. Genomics 79, 573-581.
5. Kong Z, Xie D, Boike T, Raghavan P, Burma S, Chen DJ, Habib AA, Chakraborty A, Hsieh JT, and Saha D (2010). Downregulation of human DAB2IP gene expression in prostate cancer cells results in resistance to ionizing radiation. Cancer Res 70, 2829-2839.
6. Kong Z, Raghavan P, Xie D, Boike T, Burma S, Chen D, Chakraborty A, Hsieh JT, and Saha D (2010). Epothilone B confers radiation dose enhancement in DAB2IP gene knock-down radioresistant prostate cancer cells. Int J Radiat Oncol Biol Phys 78, 1210-1218.
7. Lee SH and Kim CH (2002). DNA-dependent protein kinase complex: a multifunctional protein in DNA repair and damage checkpoint. Mol Cells 13, 159-166.
8. Woo RA, Jack MT, Xu Y, Burma S, Chen DJ, and Lee PW (2002). DNA damage-induced apoptosis requires the DNA-dependent protein kinase, and is mediated by the latent population of p53. EMBO J 21, 3000-3008.
9. Callen E, Jankovic M, Wong N, Zha S, Chen HT, Difilippantonio S, Di Virgilio M, Heidkamp G, Alt FW, Nussenzweig A, et al. (2009). Essential role for DNA-PKcs in DNA double-strand break repair and apoptosis in ATM-deficient lymphocytes. Mol Cell 34, 285-297.
10. Shaheen FS, Znojek P, Fisher A, Webster M, Plummer R, Gaughan L, Smith GC, Leung HY, Curtin NJ, and Robson CN (2011). Targeting the DNA double strand break repair machinery in prostate cancer. PloS One 6, e20311.
11. Daido S, Yamamoto A, Fujiwara K, Sawaya R, Kondo S, and Kondo Y (2005). Inhibition of the DNA-dependent protein kinase catalytic subunit radiosensitizes malignant glioma cells by inducing autophagy. Cancer Res 65, 4368-4375.
12. Yang ZJ, Chee CE, Huang S, and Sinicrope FA (2011). The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther 10, 1533-1541.
13. Bae H and Guan JL (2011). Suppression of autophagy by FIP200 deletion impairs DNA damage repair and increases cell death upon treatments with anticancer agents. Mol Cancer Res 9, 1232-1241.
14. Edinger AL and Thompson CB (2003). Defective autophagy leads to cancer. Cancer Cell 4, 422-424.
15. Apel A, Herr I, Schwarz H, Rodemann HP, and Mayer A (2008). Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy. Cancer Res 68, 1485-1494.
16. Tanida I, Ueno T, and Kominami E (2004). LC3 conjugation system in mammalian autophagy. Int J Biochem Cell Biol 36, 2503-2518.
17. Sou YS, Tanida I, Komatsu M, Ueno T, and Kominami E (2006). Phosphatidylserine in addition to phosphatidylethanolamine is an in vitro target of the mammalian Atg8 modifiers, LC3, GABARAP, and GATE-16. J Biol Chem 281, 3017-3024.
18. Rouschop KM, van den Beucken T, Dubois L, Niessen H, Bussink J, Savelkouls K, Keulers T, Mujcic H, Landuyt W, Voncken JW, et al. (2010). The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. J Clin Invest 120, 127-141.
19. Kondo Y, Kanzawa T, Sawaya R, and Kondo S (2005). The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 5, 726-734.
20. Zoncu R, Efeyan A, and Sabatini DM (2011). mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12, 21-35.
21. Zeng X and Kinsella TJ (2008). Mammalian target of rapamycin and S6 kinase 1 positively regulate 6-thioguanine-induced autophagy. Cancer Res 68, 2384-2390.
22. Scott RC, Schuldiner O, and Neufeld TP (2004). Role and regulation of starvation-induced autophagy in the Drosophila fat body. Dev Cell 7, 167-178.
23. Klionsky DJ, Meijer AJ, and Codogno P (2005). Autophagy and p70S6 kinase. Autophagy 1, 59-60; discussion 60-51.
24. Amaravadi RK, Yu D, Lum JJ, Bui T, Christophorou MA, Evan GI, Thomas-Tikhonenko A, and Thompson CB (2007). Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 117, 326-336.
25. Chen H, Tu SW, and Hsieh JT (2005). Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer. J Biol Chem 280, 22437-22444.
26. Xie D, Gore C, Zhou J, Pong RC, Zhang H, Yu L, Vessella RL, Min W, and Hsieh JT (2009). DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis. Proc Natl Acad Sci USA 106, 19878-19883.
27. Xie D, Gore C, Liu J, Pong RC, Mason R, Hao G, Long M, Kabbani W, Yu L, Zhang H, et al. (2010). Role of DAB2IP in modulating epithelial-tomesenchymal transition and prostate cancer metastasis. Proc Natl Acad Sci USA 107, 2485-2490.
28. Hefferin ML and Tomkinson AE (2005). Mechanism of DNA double-strand break repair by non-homologous end joining. DNA Repair (Amst) 4, 639-648.
29. Um JH, Kwon JK, Kang CD, Kim MJ, Ju DS, Bae JH, Kim DW, Chung BS, and Kim SH (2004). Relationship between antiapoptotic molecules and metastatic potency and the involvement of DNA-dependent protein kinase in the chemo-sensitization of metastatic human cancer cells by epidermal growth factor receptor blockade. J Pharmacol Exp Ther 311, 1062-1070.
30. Tonotsuka N, Hosoi Y, Miyazaki S, Miyata G, Sugawara K, Mori T, Ouchi N, Satomi S, Matsumoto Y, Nakagawa K, et al. (2006). Heterogeneous expression of DNA-dependent protein kinase in esophageal cancer and normal epithelium. Int J Mol Med 18, 441-447.
31. Shintani S, Mihara M, Li C, Nakahara Y, Hino S, Nakashiro K, and Hamakawa H (2003). Up-regulation of DNA-dependent protein kinase correlates with radiation resistance in oral squamous cell carcinoma. Cancer Sci 94, 894-900.
32. Beskow C, Skikuniene J, Holgersson A, Nilsson B, Lewensohn R, Kanter L, and Viktorsson K (2009). Radioresistant cervical cancer shows upregulation of the NHEJ proteins DNA-PKcs, Ku70 and Ku86. Br J Cancer 101, 816-821.
33. Leahy JJ, Golding BT, Griffin RJ, Hardcastle IR, Richardson C, Rigoreau L, and Smith GC (2004). Identification of a highly potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor (NU7441) by screening of chromenone libraries. Bioorg Med Chem Lett 14, 6083-6087.
34. Kroemer G, Marino G, and Levine B (2010). Autophagy and the integrated stress response. Mol Cell 40, 280-293.
35. Alva AS, Gultekin SH, and Baehrecke EH (2004). Autophagy in human tumors: cell survival or death? Cell Death Differ 11, 1046-1048.
36. Bergmann A (2007). Autophagy and cell death: no longer at odds. Cell 131, 1032-1034.
37. Chaachouay H, Ohneseit P, Toulany M, Kehlbach R, Multhoff G, and Rodemann HP (2011). Autophagy contributes to resistance of tumor cells to ionizing radiation. Radiother Oncol 99, 287-292.
38. Mathew R, Kongara S, Beaudoin B, Karp CM, Bray K, Degenhardt K, Chen G, Jin S, and White E (2007). Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev 21, 1367-1381.
39. Kimmelman AC (2011). The dynamic nature of autophagy in cancer. Genes Dev 25, 1999-2010